EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Multiomics Research Strategies in Cancer: A Growing and Innovative Field

Zhenhua Du, Xiaomei Liu, Zhi Lv, Bengang Wang, Yu Xia, Wala Abduljabbar Mohammed Al-Duais, Lirong Yan, Fuqiang Zhang, Yanke Li

MedComm · 2026-04 · 7 (4)

DOI: 10.1002/mco2.70644 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 24.03.2026. Verfasst von Zhenhua Du und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecology and Obstetrics Shengjing Hospital of China Medical University Shenyang China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 316 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Liaoning Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is a highly complex and heterogeneous disease involving multiple pathophysiological events. Despite significant advances in modern medicine, the molecular mechanisms of cancer are still largely unknown. Omics methods have opened new avenues for identifying cancer biomarkers and elucidating disease pathogenesis. However, single‐omics approaches only provide a limited understanding of biological mechanisms. The comprehensive analysis of multiomics data will provide useful insights for the pathogenesis, identification of therapeutic targets, and discovery of biomarkers in cancer. Here, we reviewed the disease signatures of cancer. We then reviewed the current state of multiomics biomarkers research in cancer. To further delineate the upstream pathogenic changes and downstream molecular effects of cancer, we also discuss the current strategies for integrating multiomics data using deep learning approaches. In addition, single‐cell and spatial omics are being used to guide treatment strategies, risk assessment, and early diagnosis, as well as their potential impact on precision medicine. Despite the relative youth of the field, the development of single‐cell and spatial omics promises to provide a powerful tool for elucidating the pathogenesis of cancer.

Schlagwörter

Stichwörter der Autor:innen

biomarkerscancerdeep learningmultiomicsprecision medicinesingle‐cell omicsspatial omics

Autor:innen und Institutionen

  • Department of Gynaecology and Obstetrics Shengjing Hospital of China Medical University Shenyang China.
  • Department of Anorectal Surgery First Hospital of China Medical University Shenyang China.
  • Department of Hepatobiliary Surgery First Hospital of China Medical University Shenyang China.
  • The First Laboratory of Cancer Institute First Hospital of China Medical University Shenyang China.

Förderung

  • Natural Science Foundation of Liaoning Province

Zitieren

APA

Du, Z., Liu, X., Lv, Z., Wang, B., Xia, Y., Al-Duais, W. A. M., Yan, L., Zhang, F., & Li, Y. (2026). Multiomics Research Strategies in Cancer: A Growing and Innovative Field. MedComm, 7(4). https://doi.org/10.1002/mco2.70644

Vancouver

Du Z, Liu X, Lv Z, Wang B, Xia Y, Al-Duais WAM, et al. Multiomics Research Strategies in Cancer: A Growing and Innovative Field. MedComm. 2026;7(4). doi:10.1002/mco2.70644

BibTeX
@article{Du2026,
  author = {Du, Zhenhua and Liu, Xiaomei and Lv, Zhi and Wang, Bengang and Xia, Yu and Al-Duais, Wala Abduljabbar Mohammed and Yan, Lirong and Zhang, Fuqiang and Li, Yanke},
  title = {Multiomics Research Strategies in Cancer: A Growing and Innovative Field},
  journal = {MedComm},
  year = {2026},
  volume = {7},
  number = {4},
  doi = {10.1002/mco2.70644}
}
Kostenlos starten →